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ABSTRACT 
Purpose: Age-related cataract is one of the leading causes of blindness and avoidable visual 
impairment in the world. There is no time-tested, FDA-approved, or clinically proven medical 
treatment exists till date to delay, prevent, or reverse the progression of senile cataract. Nirgundi 
(Vitex negundo) is a Chakshushya single drug mentioned in Ayurvedic classics. Various animal 
experimental study and invitro studies in recent years using flavonoids extracted from leaves of 
Vitex negundo on selenite induced cataract models proved to be beneficial in arresting the 
progression of cataract. Hence a clinical study with Vitex negundo eye drops in the form of Arka 
was planned with primary objective to assess the effect of Nirgundi patra arka as Aschotana (eye 
drops) in pre senile cataract. Methods: The study design was interventional pre and post 
evaluation without control. Patients were advised to instill Nirgundi patra arka two drops thrice 
daily i.e. 6 am, 12 pm and 6pm for a period of 6months. Log mar visual acuity score and contrast 
sensitivity score were recorded before treatment, 3rd month of treatment, after treatment, 9th 
month (1st follow up) and 12th month (2nd follow up). Slit lamp photographs were recorded before 
treatment and 12th month. Study and follow up were done in 31 eyes. Result: The intervention is 
statistically significant while considering visual acuity and contrast sensitivity. All the 27 cases of 
nuclear cataract responded to the intervention, while only 83.3% of posterior sub capsular 
cataract and 60% of cortical cataract showed response. But the change was not significant 
statistically. Conclusion: The intervention was effective in improving visual acuity and contrast 
sensitivity in all types of pre senile cataract. Clinical assessment revealed the study was effective 
in preventing the progression of pathogenesis in early stage of nuclear cataract.  
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INTRODUCTION 
Globally 285 million people are affected by 
visual impairment, of which 80% of visual 
impairment is avoidable. Cataract (33%) and 
uncorrected refractive errors (42%) are the leading 
causes of avoidable visual impairment. Unoperated 
Cataract (51% i.e. about 20 million people) and 
Glaucoma (8%) are the leading causes of avoidable 
blindness (2010). The WHO estimates that cataract 
blindness will reach 40 million by 20201. Aging is 
the most common aetiological factor contributing 
to the disease cataract. There is no single 
universally accepted pharmacological agent that 
can either inhibit or reverse the progression of 
cataract. 
 At present, the most effective conventional 
treatment of cataract is the surgical extirpation of 
opacified lens and IOL implantation. In spite of the 
progress made in surgical techniques during the 
last ten years, cataract remains the leading cause of 
visual impairment in all areas of the world, except 
for developed countries. The WHO proposes that 
between 2000 and 2020, number of cataract 
surgeries performed worldwide have to be tripled 
to keep pace with the need of population.[1]  
Department of Biochemistry of Kerala 
University, Karyavattom campus conducted various 
invivo and invitro studies, using flavonoids extracted 
from leaves of Vitex negundo on selenite induced 
cataract models in the recent years, considering the 
role of free radical mediated oxidative stress in 
pathogenesis of cataract[2-6]. Luteolin is a bioactive 
flavonoid isolated and characterized from the leaves 
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of Vitex negundo. Studies were conducted to prove 
the role of luteolin in preventing selenite induced 
oxidative stress and cataract. This was done by 
extraction of lens from Sprague Dawley strain rats 
and was organ cultured in DMEM medium.  
After experimental study period, lenses were 
taken out and various parameters were studied. It 
was found that luteolin treatment abated selenite 
induced oxidative stress and cataractogenesis by 
maintaining antioxidant status, reducing Reactive 
Oxygen Species Generation and lipid peroxidation in 
the lens. This firmly demonstrated the anticataracto-
genic effect of luteolin by virtue of its antioxidant 
property. [2]  
On the basis of the above studies this clinical 
study is attempted as the next phase. The main 
intention of the study was to assess the effect of drug 
in preventing or reversing the progression of cataract 
at the pre senile stage. So the age group of the study 
was pre fixed as 40-50.  
Acharyas explained various diseases affecting 
eye and visual function in Ayurveda Samhithas. The 
progressive nature of blindness in Thimira-kacha-
linganasa has clinical similarity with progressing 
nature of senile cataract. The similarity in surgery 
done in Kaphaja linganasa points the condition to be 
that of mature cataract. So the disease cataract may 
be compared to Thimira-kacha-linganasa.  
 Among all Kalpana, Arka kalpana is 
mentioned as the most potent form of drug 
preparation by Lord Ravana in Arkaprakasa7. It is 
user friendly and has long shelf life of 6 months to 1 
year. It does not require any preservatives; frequent 
dose of medicines can be easily administered. Above 
all various Arka preparations in the form of eye drops 
have been using in our department for long, which 
are proved to be beneficial in various ocular diseases. 
The disease cataract requires long period of 
medication and long duration of follow up. 
Considering all these factors Arka prepared from 
Nirgundi leaves (blue flowered variety) in the form of 
Aschothana was planned in the study as intervention 
drug. The pilot study conducted in the Out Patient 
Department is found to be relatively safe, user 
friendly and beneficial. 
In this clinical trial, 51 eyes of patients 
between the age group 40-50 years having the 
features of cataract, based on slit lamp photographs 
were selected. Visual acuity was assessed by the log 
Mar visual acuity chart and contrast sensitivity was 
assessed by the Pelli Robson contrast sensitivity 
chart. These patients were given Nirgundi patra arka 
in sterile glass dropper bottles and was advised to 
instill two drops of Arka three times daily (6am, 
12noon, and 6pm) for a period of 6 months.  
Out of these 51 eyes, only 31 eyes came 
regularly to collect medicines and for follow up. 
Remaining 20 cases were considered as dropouts of 
the study. Assessment of visual acuity and contrast 
sensitivity were done in 3rd month during 
medication, 6th month after treatment and in 9th and 
12th month as the follow up. 
 Slit lamp photographs were taken from the 
Regional Institute of Ophthalmology prior to the 
treatment and 12th month during last follow up 
period. Study was supervised and monitored by the 
co-guide from Regional Institute of Ophthalmology 
during the selection of patients, throughout the study 
period and during grading of cataract. Grading of 
cataract was done before treatment and during last 
follow up (12th month) based on LOCS III and was 
analyzed. 
AIM AND OBJECTIVE OF THE STUDY 
To evaluate the effect of Nirgundi patra arka 
as Aschothana (eye drops) in cataract. 
Methodology  
Study Design  
Interventional study with pre and post 
evaluation without control.  
Study Setting 
Department of Salakyatantra, Govt. Ayurveda 
College, Trivandrum. 
Study Population  
Patients diagnosed as having cataract from 
OPD of Salakyatantra, Govt: Ayurveda College, 
Trivandrum, fulfilling the inclusion and exclusion 
criteria.  
Inclusion Criteria 
Patients having cataract aged 40-50 
irrespective of sex. 
Exclusion Criteria 
1. Patients suffering from inflammatory and 
infective disease of eyeball and its appendages  
2. Patients on local and systemic steroid medication.  
3. Patients with history of steroid intake.  
4. Patients having Diabetes Mellitus  
5. Traumatic cataract  
Sample Size  
The proposed sample size was 40 eyes, 
considering the long duration of study and follow up 
51 eyes were selected. Among them only 31 cases 
came regularly to collect medicine and for follow up. 
Remaining 20 cases were considered as drop outs of 
the study.  
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Study Tool 
Case proforma 
A structured questionnaire 
Investigations 
 LogMar Chart  
 Pelli-Robson Contrast Sensitivity Chart  
 Slit lamp photography  
Procedure 
The patients diagnosed as having cataract and 
registered in OPD of Salakyatantra, Govt. Ayurveda 
College Hospital, Trivandrum, are selected as per 
inclusion and exclusion criteria. 
Preparation of medicines  
Fresh leaves of Nirgundi (blue variety) were 
collected in the morning and were washed properly 
with water. Equal amount of distilled water was 
added to it and kept in sunlight for 1 Gadi, i.e. 24 
minutes.[8] Then immediately transferred into the 
Arka yantra (distillation unit) and subjected to 
distillation process. The distillate obtained was 
filtered under sterile conditions collected to glass 
bottle. This was kept in medicinal shelf under 
hygienic conditions away from light and heat. 
Analytical study of Nirgundi patra arka 
Organoleptic Characters  
Colour : Transparent. 
Odour : Smell of Nirgundi. 
Touch : Cold 
Taste : As that of Nirgundi 
Consistency : Liquid 
 Analytical Values 
Specific gravity : 1.0001 
Refractive index : 1.30 
Solid content : 0.14 % 
Volatile oil content : 0.5 % 
PH : 5.81 
T.L.C 
T.L.C of Ethyl acetate extract of Nirgundi 
patra arka on silica gel plate using solvent system 
Toluene: Ethyl acetate: Formic acid in the ratio 20:5:1 
under U.V (366nm) one fluorescent zone at Rf:.5 
Interventions 
After all clinical examination and 
investigations they were given Nirgundi patra arka as 
eye drop and the procedure of administration was 
demonstrated to them. The patients were directed to 
instil eye drops for a period of 6 months two drops 
thrice daily (6am, 12noon, 6pm). 
Assessment of the patients and follow up 
Clinical evaluation and investigations was 
done prior to the commencement of intervention, i.e., 
before study and consecutive assessments was made 
on the 3rd month medication, 6th month after 
medication and subsequent every third month till 
one year as follow up to assess the outcome. 
Outcome Variable 
1. Change in contrast sensitivity by Pelli - Robson 
contrast sensitivity chart  
2. Change in vision by Log Mar visual acuity chart  
3. Grading of cataract using slit lamp photography 
Statistical Analysis 
Quantitative variables were described by mean, 
standard deviation, minimum and maximum. Paired 
comparison of quantitative variables were analysed 
by paired ‘t’ test or ‘Wilcoxon Signed Rank’ test 
according to the nature of data. ‘P’ value of 0.05 was 
taken as the level of significance. 
Ethical Considerations 
 Consent from the patient. 
 Consent from Head of institute. 
 Consent from Regional Institute of 
Ophthalmology was obtained prior to study. 
RESULTS  
Out of 51 eyes selected for study 70.59% of 
eye were having nuclear cataract, 21.57% were with 
mixed type of cataract, 5.88% were with posterior 
sub capsular cataract and 1.96 % were having 
cortical type of cataract. This is because nuclear 
opacities are the most commonly seen type of age 
related cataract. 
Table No: 1 Contrast Sensitivity Analysis 
Assessment period N 
Contrast Sensitivity Assesment 
MEAN SD 
Before treatment-BT 31 1.55 0.36 
During treatment-DT 31 1.79 0.24 
After treatment-AT 31 2.12 0.11 
1st follow up-AF1 31 2.14 0.11 
2nd follow up-AF2 31 2.14 0.11 
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Graph No: 1  
 
Table No: 2 Contrast Sensitivity Comparison 
Paired comparison using paired 
‘t’ test 
Paired Differences Paired t test 
MEAN SD t P 
BT- DT .240 .283 4.734 <0.001 
BT- AT .573 .325 9.816 <0.001 
BT-AF1 .592 .330 9.974 <0.001 
BT- AF2 .592 .333 9.906 <0.001 
AT- AF2 .019 .051 2.108 .043 
 Average change in contrast sensitivity between BT & DT, BT & AT, BT & AF1, BT & AF 2 and AT & AF2 is given. 
The p value obtained shows that difference is statistically significant.  
Table No: 3 Logmar Visual Acuity Analyses 
Assessment period N 
Logmar Visual Acuity Assessment 
MEAN SD 
Before treatment-BT 31 0.56 0.25 
During treatment-DT 31 0.49 0.23 
After treatment-AT 31 0.40 0.20 
1st follow up-AF1 31 0.39 0.19 
2nd follow up-AF2 31 0.40 0.20 
Graph No: 2 
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Table No: 4 Log Mar Visual Acuity Comparison 
Paired comparison 
Paired Differences Paired t test 
MEAN SD t P 
BT- DT .071 .101 3.926 <0.001 
BT- AT .155 .155 5.577 <0.001 
BT-AF1 .165 .156 5.868 <0.001 
BT- AF2 .161 .154 5.823 <0.001 
AT- AF2 .006 .025 1.438 .161 
Average change in log Mar visual acuity between BT & DT, BT & AT, BT & AF1, and BT & AF 2 given. The p value 
obtained shows that difference is statistically significant. While comparing AT –AF2,, the p value obtained is.161 
which shows no significant improvement in visual acuity.  
Assessment of Nuclear Cataract  
Table No: 5 Analysis of data related to nuclear cataract 
Nuclear Cataract  
 BT  AF2 
N % N % 
Grade 1 9 33.3 12 44.4 
Grade 2 18 66.7 15 55.6 
Total 27 100.0 27 100.0 
Wilcoxon signed rank test Z=1.732: P=0.083 
In the case of 27 nuclear cataract eyes, before treatment assessment revealed 33.3% (9 eyes) of grade I cataract 
and 66.7 % (18 eyes) of grade II cataract. During 12th month assessment 44.4 % (12 eyes) of grade I and 55.6 
% (15 eyes) of grade II cataract were reported.  
Graph No: 3 
 
Here the calculated p value (0.083) is greater than 0.05.hence the test is statistically not significant, that means 
the change in grade of cataract with the intervention is not significant statistically. 
Assessment of Cortical Cataract 
Table No: 6 Analysis of data related to cortical cataract 
Cortical 
Cataract 
 BT  AF2 
N % N % 
Grade 2 5 100.0 3 60.0 
Grade 3 0 0 2 40.0 
Total 5 100.0 5 100.0 
Wilcoxon signed rank test Z= 1.414: P=0.157 
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In the case of 5 cortical cataract eyes, before treatment assessment revealed 100% (5 eyes) of grade II cataract 
and during 12th month assessment 60 % (3 eyes) of grade II and 40% (2 eyes) of grade III cataract were 
reported.  
Graph No: 4  
 
Here the calculated p value (0.157) is greater than 0.05.Hence the test is statistically not significant, that means 
the change in grade of cataract with the intervention is not significant statistically. 
Assessment of Posterior Sub Capsular Cataract 
Table No: 7: Analysis of data related to PSCC 
 BT  AF2 
PSCC N % N % 
Grade 1 1 16.7 1 16.7 
Grade 2 1 16.7 0 0 
Grade 3 4 66.7 5 83.3 
Total 6 100.0 6 100.0 
Wilcoxon signed rank test z= 1.000 p=0.317 
In the case of 6 PSCC eyes, before treatment assessment revealed 16.17% (1 eye) of grade I cataract, 16.7 % (1 
eye) of grade II and 66.7% of grade III. During 12th month assessment 16.7 % (1 eye) of grade I and 83.3 % (5 
eyes) of grade III cataract were reported.  
Graph No: 5  
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Images of Some Photographs Obtained [BT-AF2] 
Nuclear Cataract 
  
Fig: 1 BT-grade II Fig: 2 AF2-grade I 
Cortical Cataracts 
  
Fig: 5 BT Grade II Fig: 6 AT Grade III 
PSCC 
  
Fig: 7 BT Grade I   Fig: 8 AF2 –Grade I 
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PSCC 
  
Fig: 11 BT Grade III Fig: 12 AF2 Grade III 
 
Here the calculated p value (0.317) is greater 
than 0.05.Hence the test is statistically not significant, 
that means the change in grade of cataract with the 
intervention is not significant statistically.  
Summary  
Statistically analyzed comparison results 
between BT-DT, BT-AT, BT–AF1 and AT-AF2 
suggested there was significant improvement in 
contrast sensitivity. In the case of visual acuity there 
was significant improvement while comparing BT-
DT, BT-AT, BT–AF1 and BT-AF2. There was no 
significant improvement in visual acuity on 
comparing AT –AF2, but the improved visual acuity 
sustained and there was no deterioration of vision 
noted throughout follow up period. 
Slit lamp photographs obtained shows that: 
In case of nuclear cataract, 
 The whole 33.3% of grade I cataract was 
responded with intervention and persisted in the 
state of grade I.  
 Among 66.7% of grade II cataract, 55.6% 
remained in grade II and 11.12% improved to 
grade I. That means in the case of nuclear cataract 
the intervention is effective. 
In the case of cortical cataract,  
 Even though the sample size is small, 60% of 
grade 2 type responded with the intervention but 
the remaining were not.  
In the case of posterior sub capsular cataract, 
 Even though the sample size is small, 16.7% of 
grade 1 and 66.7% of grade 3 responded to the 
treatment but 16.7% were not responded. 
The clinical study revealed that the 
intervention is effective in improving visual acuity 
and contrast sensitivity in all forms of cataract. That 
means the study is statistically significant while 
considering visual acuity and contrast sensitivity 
assessment. The intervention was more effective in 
nuclear cataract when compared with cortical and 
posterior sub capsular cataract in preventing the 
progress of pathogenesis. Here the study is not 
statistically significant but it can arrest the 
progression of cataract in the initial stage. 
Probable Mode of Action of Drug 
Nuclear Cataract 
Vata vaigunya cause Soshana of Drava guna 
and Kshaya of Snigdha guna of Kapha, which 
increases Sthira guna of Kapha (Kapha sanchaya in 
lens). Rooksha guna of Vata leads to sclerotic changes 
in lens, and Pitta vikrithi cause accumulation of 
metabolic by-product (Mala sanchaya). Nirgundi is a 
drug having Vata kaphahara property9 which 
normalize Vikrutha gunas of vata and Kapha. The 
Thiktha kashaya rasa of drug pacifies Pitta dosha. It 
posses deepana and Chakshushya karma[10], which 
help in maintaining function of Pitta. Thus help in 
maintaining the anti-oxidant state & prevent 
progression of cataract. 
Cortical Cataract 
Stage of hydration: Relative Kapha vridhi occurs in 
lens. The normal Sthairya sangatha property of the 
lens fibre is lost and Vishyandhana, kledana and 
Gourava occurs in the cortex of lens. 
Denaturation of proteins: This stage may be 
inferred as loss of Drava guna and Sneha guna of 
normal soluble crystalline protein thereby increasing 
Sthira and Rooksha guna, transforming it into an 
insoluble form. Vata kapha samanatwa of Nirgundi 
normalize the Vikritha gunas of Vata and Kapha in 
cataract. Along with this Sopha hara property[10] also 
help in reversal of the stage of hydration 
Posterior sub capsular cataract 
Vikrithi of Vata occurs in old age to those who 
are resort to Vatika ahara vihara. Gathi, the property 
of Vayu is getting hampered and abnormal migration 
of lens epithelium occurs. Abnormal Vibajana by this 
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Vikrutha vayu results in the formation of aberrant 
lens fibres. Vatahara and Chakshushya nature of 
Nirgundi balancing Vata to its equilibrium stage. 
Functional impairment in cataract 
The Chala (accommodation, refraction, 
transport), Visada (transparency), Sookshma 
(permeation of light) Gunas of Vata and Ushma guna 
(Alochaka agni) of Pitta are impaired in cataract. Vata 
kapha hara property, Ushna veerya, and Lagu guna of 
Nirgundi helps in normalizing Vikrutha gunas of 
Dosha to a great extent. This improves transparency 
of lens and makes it permeable to light rays to pass 
through. Deepana, Sophahara, Chakshushya karma of 
Nirgundi also helps in maintaining normal function of 
lens. Thus contrast sensitivity and visual acuity 
improved in patients to a great extent. 
CONCLUSION 
Age related cataract is most common among 
all types of cataract. Nuclear cataract is the 
commonest form of age related cataract. The 
intervention was effective in improving visual acuity 
and contrast sensitivity in all types of age related 
cataract in the early stage. Clinical assessment 
revealed the study was significant in preventing the 
progression of pathogenesis of nuclear cataract in the 
presenile stage. The study drug was found to be safe 
and user friendly Sample size was not adequate to 
minimize the sampling and systematic error. Long 
duration follow up was excused for the attrition of 
cases from the sample. Study has to be conducted by 
employing large sample size. Evaluation of 
biochemical changes on administration of medicine 
have to be studied incorporating the advanced 
technologies. 
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